Yungjin Pharm Co Ltd
KRX:003520
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Yungjin Pharm Co Ltd
Cash from Investing Activities
Yungjin Pharm Co Ltd
Cash from Investing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Yungjin Pharm Co Ltd
KRX:003520
|
Cash from Investing Activities
-₩11.9B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
1%
|
|
|
Yuhan Corp
KRX:000100
|
Cash from Investing Activities
-₩71B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
5%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Cash from Investing Activities
-₩35.4B
|
CAGR 3-Years
28%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Cash from Investing Activities
-₩159.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-3%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Cash from Investing Activities
-₩42.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-12%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Cash from Investing Activities
₩16.5B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
Yungjin Pharm Co Ltd
Glance View
Yungjin Pharm.Co., Ltd. engages in the development, production, and distribution of pharmaceuticals. The company is headquartered in Seoul, Seoul. The firm mainly manufactures and sells pharmaceutical products including antibiotics, respiratory drugs, anti-infective drugs, antipyretics, analgesics, central nervous system (CNS) drugs, gastrointestinal (GI) drugs, cardiovascular (CV) drugs, antihistamines, antifungals, antidiabetics, vitamin nutrients, antibiotic raw materials, and others. The firm also engages in the leasing of real estates.
See Also
What is Yungjin Pharm Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
-11.9B
KRW
Based on the financial report for Dec 31, 2025, Yungjin Pharm Co Ltd's Cash from Investing Activities amounts to -11.9B KRW.
What is Yungjin Pharm Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
1%
Over the last year, the Cash from Investing Activities growth was 35%. The average annual Cash from Investing Activities growth rates for Yungjin Pharm Co Ltd have been 4% over the past three years , -16% over the past five years , and 1% over the past ten years .
